POLE and colorectal carcinoma: Furthermore, expression of cytotoxic T-cell markers (CD8A, IFNG, and PRF), effector cytokines (CXCL9 and CXCL10), and immune checkpoint proteins (PD-1, PD-L1, and CTLA-4) is significantly increased in PolE-mutant CRC [44].